These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 17933687)

  • 1. Evaluation of HIF-1 inhibitors as anticancer agents.
    Semenza GL
    Drug Discov Today; 2007 Oct; 12(19-20):853-9. PubMed ID: 17933687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting HIF-1 for cancer therapy.
    Semenza GL
    Nat Rev Cancer; 2003 Oct; 3(10):721-32. PubMed ID: 13130303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of novel inhibitors targeting HIF-1α towards anticancer drug discovery.
    Yewalkar N; Deore V; Padgaonkar A; Manohar S; Sahu B; Kumar P; Jalota-Badhwar A; Joshi KS; Sharma S; Kumar S
    Bioorg Med Chem Lett; 2010 Nov; 20(22):6426-9. PubMed ID: 20932758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A quassinoid 6alpha-tigloyloxychaparrinone inhibits hypoxia-inducible factor-1 pathway by inhibition of eukaryotic translation initiation factor 4E phosphorylation.
    Jin X; Jin HR; Lee D; Lee JH; Kim SK; Lee JJ
    Eur J Pharmacol; 2008 Sep; 592(1-3):41-7. PubMed ID: 18639543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The hypoxic inducible stress response as a target for cancer drug discovery.
    Welsh SJ; Koh MY; Powis G
    Semin Oncol; 2006 Aug; 33(4):486-97. PubMed ID: 16890803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent advances in hypoxia-inducible factor (HIF)-1 inhibitors.
    Xia Y; Choi HK; Lee K
    Eur J Med Chem; 2012 Mar; 49():24-40. PubMed ID: 22305612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIF-1 inhibitors for cancer therapy: from gene expression to drug discovery.
    Semenza GL
    Curr Pharm Des; 2009; 15(33):3839-43. PubMed ID: 19671047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibiting hypoxia-inducible factor 1 for cancer therapy.
    Melillo G
    Mol Cancer Res; 2006 Sep; 4(9):601-5. PubMed ID: 16940159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Poly(ADP-ribose) polymerase 1 promotes tumor cell survival by coactivating hypoxia-inducible factor-1-dependent gene expression.
    Elser M; Borsig L; Hassa PO; Erener S; Messner S; Valovka T; Keller S; Gassmann M; Hottiger MO
    Mol Cancer Res; 2008 Feb; 6(2):282-90. PubMed ID: 18314489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reactive oxygen species and HIF-1 signalling in cancer.
    Galanis A; Pappa A; Giannakakis A; Lanitis E; Dangaj D; Sandaltzopoulos R
    Cancer Lett; 2008 Jul; 266(1):12-20. PubMed ID: 18378391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of hypoxia-inducible factor 1alpha expression and its effects on invasion and metastasis.
    Krishnamachary B; Semenza GL
    Methods Enzymol; 2007; 435():347-54. PubMed ID: 17998062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Recent progress in the study on antitumor drugs targeting hypoxia-inducible factor-1].
    Wang JJ; Li J; Geng MY
    Yao Xue Xue Bao; 2008 Jun; 43(6):565-9. PubMed ID: 18822956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypoxia-inducible factor 1 inhibitors.
    Melillo G
    Methods Enzymol; 2007; 435():385-402. PubMed ID: 17998065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIF gene expression in cancer therapy.
    Chan DA; Krieg AJ; Turcotte S; Giaccia AJ
    Methods Enzymol; 2007; 435():323-45. PubMed ID: 17998061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting the hypoxia-inducible factor (HIF) pathway in cancer.
    Poon E; Harris AL; Ashcroft M
    Expert Rev Mol Med; 2009 Aug; 11():e26. PubMed ID: 19709449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strongylophorines: natural product inhibitors of hypoxia-inducible factor-1 transcriptional pathway.
    Mohammed KA; Jadulco RC; Bugni TS; Harper MK; Sturdy M; Ireland CM
    J Med Chem; 2008 Mar; 51(5):1402-5. PubMed ID: 18278856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A hypoxia-independent up-regulation of hypoxia-inducible factor-1 by AKT contributes to angiogenesis in human gastric cancer.
    Lee BL; Kim WH; Jung J; Cho SJ; Park JW; Kim J; Chung HY; Chang MS; Nam SY
    Carcinogenesis; 2008 Jan; 29(1):44-51. PubMed ID: 17984117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The intravenous anesthetics barbiturates inhibit hypoxia-inducible factor 1 activation.
    Wakamatsu T; Tanaka T; Oda S; Nishi K; Harada H; Daijo H; Takabuchi S; Kai S; Fukuda K; Hirota K
    Eur J Pharmacol; 2009 Sep; 617(1-3):17-22. PubMed ID: 19595685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anemia and cerebral outcomes: many questions, fewer answers.
    Hare GM; Tsui AK; McLaren AT; Ragoonanan TE; Yu J; Mazer CD
    Anesth Analg; 2008 Oct; 107(4):1356-70. PubMed ID: 18806052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cross-talk between NF-kappaB and HIF-1: further evidence for a significant liaison.
    Görlach A; Bonello S
    Biochem J; 2008 Jun; 412(3):e17-9. PubMed ID: 18498249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.